SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-182895
Filing Date
2021-06-04
Accepted
2021-06-04 16:05:50
Documents
12
Period of Report
2021-05-28
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d74323d8k.htm   iXBRL 8-K 35012
  Complete submission text file 0001193125-21-182895.txt   162613

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA fbrx-20210528.xsd EX-101.SCH 3084
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE fbrx-20210528_lab.xml EX-101.LAB 18887
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fbrx-20210528_pre.xml EX-101.PRE 11869
5 EXTRACTED XBRL INSTANCE DOCUMENT d74323d8k_htm.xml XML 3475
Mailing Address 1124 W CARSON STREET MRL BUILDING 3-320 TORRANCE CA 90502
Business Address 1124 W CARSON STREET MRL BUILDING 3-320 TORRANCE CA 90502 (310) 618-6994
Forte Biosciences, Inc. (Filer) CIK: 0001419041 (see all company filings)

IRS No.: 261243872 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38052 | Film No.: 21996477
SIC: 2834 Pharmaceutical Preparations